drugset / Trial / NCT02067299
A Study to Investigate the Effect of JNJ-42847922 on Polysomnography Measures in Patients With Major Depressive Disorder With Insomnia Who Are Stably Treated With Antidepressants
RandomizedCrossoverQuadruple-blindTreatment
Summary
The purpose of the study is to evaluate effect of JNJ-42847922 on sleep latency (latency to persistent sleep) in participants with major depressive disorder who are stably treated with selective serotonin reuptake inhibitor/serotonin-norepinephrine reuptake inhibitor who suffer from insomnia (inability to fall asleep).
Timeline
- Start
- 2014-02
- Primary completion
- 2014-12
- Completion
- 2014-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Seltorexant | Small molecule | 10 mg | Oral |
| Subject | Seltorexant | Small molecule | 20 mg | Oral |
| Subject | Seltorexant | Small molecule | 40 mg | Oral |